Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.98 - $115.74 $61,169 - $71,527
618 Added 7.54%
8,818 $1.02 Million
Q2 2023

Aug 14, 2023

SELL
$96.34 - $112.38 $280,927 - $327,700
-2,916 Reduced 26.23%
8,200 $843,000
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $453,748 - $479,878
4,228 Added 61.38%
11,116 $1.21 Million
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $336,656 - $614,064
-5,396 Reduced 43.93%
6,888 $783,000
Q3 2022

Nov 14, 2022

SELL
$58.92 - $84.67 $2.35 Million - $3.37 Million
-39,816 Reduced 76.42%
12,284 $760,000
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $1.7 Million - $2.5 Million
21,453 Added 70.0%
52,100 $4.16 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $1.69 Million - $2.15 Million
19,602 Added 177.47%
30,647 $3.22 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $826,425 - $1.01 Million
8,385 Added 315.23%
11,045 $1.19 Million
Q3 2021

Nov 15, 2021

BUY
$91.91 - $110.37 $244,480 - $293,584
2,660 New
2,660 $291,000
Q1 2021

May 17, 2021

SELL
$71.83 - $95.48 $4.52 Million - $6.01 Million
-62,907 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$67.0 - $84.39 $3.55 Million - $4.47 Million
52,965 Added 532.74%
62,907 $4.6 Million
Q3 2020

Nov 16, 2020

BUY
$55.23 - $79.93 $549,096 - $794,664
9,942 New
9,942 $772,000
Q2 2020

Aug 17, 2020

SELL
$30.2 - $56.98 $1.26 Million - $2.38 Million
-41,844 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$24.87 - $38.56 $1.04 Million - $1.61 Million
41,844 New
41,844 $1.24 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.